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2ABSTRACT
Objective We studied whether primary care temporomandibular disorder (TMD) patients reporting
different levels of pain-related disability differ in terms of comorbid pains, general health conditions,
and quality of life.
Material and Methods Consecutive TMD pain patients (n = 399) seeking treatment in primary care
completed a questionnaire on comorbid pains and their interference and the Finnish version of the
RAND-36-item quality of life questionnaire. Medical diagnoses confirmed by doctors were recorded.
The patients were classified according to the Graded Chronic Pain Scale (GCPS) of the Research
Diagnostic Criteria for TMD (RDC/TMD). The patients were classified: no disability group (0
disability points), low disability group (1–2 disability points) and high disability group (3–6 disability
points).
Results Compared to patients in the no-disability group, patients in the high- and low-disability
groups reported more comorbid pain conditions(P<0.001), and experienced these as more intense
and interfering more with daily life(P<0.05). Patients in the high-disability group reported more
general health-related medical diagnoses than patients in the no-disability group(P<0.05).
Furthermore, patients with low or high pain-related disability indicated poorer quality of life in all
RAND-36 subscales than those with no disability (P<0.05).
Conclusion The findings suggest that GCPS-related disability scoring can be used as a simple
screening instrument to identify TMD patients with different degrees of health burdens.
Key words: Disability evaluation, Chronic pain, Comorbidity, Temporomandibular disorders, Quality
of life
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3Introduction
Temporomandibular disorders (TMD, i.e. masticatory muscle and temporomandibular joint pain and
dysfunction) is a common reason for seeking care [1]. The prognosis of TMD is mostly favorable
[2,3], and the pain of the majority of patients is relieved by simple treatments [4]. Some patients,
however, suffer from complicated or persistent pain symptoms [2,5].
Attention has lately been paid to the relations of TMD pain to other pain conditions [6] or general
health problems [7]. Comorbid pains or health problems complicate the nature of TMD; comorbidities
increase the risk of pain chronicity and impair the treatment outcomes [2,8,9]. Pain-related
pathophysiological mechanisms may be different in patients suffering from regional symptoms
compared to patients with multiple pain conditions [10], and these patient groups might even differ
genetically [11]. The expression of comorbid pains may also differ due to cultural influences [12].
Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) is the most common
method used to diagnose and classify TMD pain patients.  In this dual axis system, the Axis II
psychosocial assessment uses Graded Chronic Pain Scale (GCPS) to measure the extent of pain
intensity and the degree to which the pain is disabling [13]. TMD pain-related disability is associated
with psychosocial factors [14-18]. The association of pain-related disability with comorbid pain
conditions and general health factors has been explored in only a few studies. The more disabled
patients have been found to report more widespread pain [8], more bodily pain [15], to rate their
general health as poorer [14,17], and to use more health services [14]. The association of pain-related
disability with comorbid pains, general health factors and health-related quality of life have not been
studied in patients seeking care for TMD pain in primary care, though the majority of these patients
are treated in primary care or by general dental practitioners [19].
The aim of the present study was to investigate comorbid pains, general health conditions, quality of
life, and use of health services of TMD pain patients in primary health care, and to study associations
of these factors with pain-related disability based on GCPS of the RDC/TMD.
4Material and methods
Study participants
This study was performed at the Department of Oral Health Care in Vantaa Health Centre, a public
primary health care organization with 200,000 inhabitants in the City of Vantaa, Finland. During a
1.5 year time period (June 2010 - November 2011), all 18-70-year-old consecutive patients contacting
Oral Health Care because of oral or facial pain were screened for possible TMD pain using validated
screening questions, as described earlier [18]. One trained dentist (UK) examined the patients to
confirm the clinical diagnosis according to the RDC/TMD criteria. Exclusion criteria included TMD
pain conditions related to acute trauma or rheumatoid or other inflammatory arthritis and any physical
or mental condition that would interfere with the ability to complete the study questionnaire. Before
inclusion in the study the patients gave their informed consent. Eleven of the total of 410 eligible
patients refused to participate. The mean age of the 399 included patients was 40.5 years (SD±12.7),
and 83% of them were women.
Subtyping of TMD patients
The data was collected using the Finnish version of the RDC/TMD Axis II questionnaire
(RDC/TMD_FIN) [20] completed by the patients at the initial visit, after the confirmation of the TMD
diagnosis. RDC/TMD Axis II GCPS was used to assess pain severity and disability [13]. The patients
were analyzed in three groups based on the GCPS disability scores in accordance with the results of
our prior studies [17,18] as follows: 1) no-disability group, i.e. Grade I and II patients with no
disability points, 2) low-disability group, i.e. Grade I and II patients with 1-2 disability points, and 3)
high-disability group, i.e. Grade III and IV patients with 3–6 disability points. From the 399 patients,
242 (61%) belonged to the no-disability group, 108 (27%) to the low-disability group and 49 (12%)
to the high-disability group.
 Comorbid pain conditions
The patients were asked about comorbid pain conditions, and their impact. The questions were
adopted and modified from Von Korff et al. [21] and from the Comorbid Pain Conditions
questionnaire (www.rdc-tmdinternational.org). The patients were asked about whether in the past six
months they had had headache, back pain, neck pain, joint pain, abdominal pain, chest pain or
fibromyalgia pain and in affirmative cases to indicate for each pain separately:
1) Pain intensity: “In the past six months, on average, how intense was your pain on a 0 to 10
     scale from  “no pain” to   “pain as bad as could be” ?
52) Days in pain: “How many days in the last six months have you been kept from your usual
activities (work, school or housework) because of the pain?”
3) Pain interference: In the past six months, how much has the pain interfered with your daily or
recreational activities, or your ability to work on a 0 to 10 scale from “no interference” to “unable to
carry on any activities”?
4) Sick leave: “How many days in the last six months have you been on sick leave because of the
pain?”
5) Use of health services: “How many times in the last six months have you consulted a doctor or
other health professional because of the pain?”
Medical diagnoses
Furthermore, the patients were asked by the examining dentist to report all doctor confirmed medical
diagnoses of sicknesses from the list that follows they had now or in the past.
The medical diagnoses were grouped into 12 categories. Each category included one or more medical
conditions; endocrine (e.g. diabetes, thyroid disease), cardiovascular (e.g. cardiologic conditions,
blood pressure), hematologic (e.g. bleeding disorder), neurosensory (e.g. epilepsy, nerve lesions,
neurologic disease), respiratory (e.g. asthma, allergy, pulmonary disease), musculoskeletal (e.g.
rheumatoid arthritis, fibromyalgia, arthrosis, back disease), headache (e.g. tension headache,
migraine), gastrointestinal (e.g. irritable bowel syndrome, gastric ulcer, diseases of liver), sleep (e.g.
sleep disorder, sleep apnea, snoring), psychiatric (e.g. depression, panic disorder, psychotic and other
mental disorders), cancer and other conditions.
Quality of life
General health-related quality of life was assessed by the Finnish version of RAND-36-item health
survey 1.0 [22]. This 36-item self-report inventory assesses both mental and physical health-related
quality of life. It includes eight health concepts: physical functioning, physical role functioning,
psychological well-being, psychological role functioning, social functioning, vitality, self-rated
general health, and bodily pain. The scores of every subscale range from 0 to 100, with higher scores
indicating better health states.
Statistical analyses
The three GCPS groups were compared with each other in studied parameters. The statistical
analysis was performed with Kruskal-Wallis One Way Analysis of Variance on Ranks followed by
6Dunn’s test or χ2-test depending on the nature of the analyzed factor [23,24] as described earlier
[25]. Intensity of pain, number of days suffered from pain and factors describing its’ interference
with everyday life, visits to doctors and amount of sick leave, as well as scores of the quality of life
were analyzed with One- Way ANOVA on ranks.  Occurrence of comorbid pain conditions and
comorbid diagnoses were analyzed with χ2-test.  A P value less than 0.05 was considered to mean a
statistically significant difference.
The amount of missing data was very low: the response rates reached 100% in all other questionnaire
and interview questions, but in the RAND-36 questionnaire there were missing data from 1-2
participants.
Results
Comorbid pain conditions
All patients, except for one patient in the no-disability group, reported comorbid pains. The mean
(SD) number of reported comorbid pains was 3.9 (±1.3). Patients in the no-disability group reported
on an average 3.6 (±1.2) comorbid pains, while the corresponding numbers were 4.2 (±1.3) in the
low, and 4.6 (±1.4) in the high-disability groups. The number of comorbid pains was significantly
lower in the no-disability group compared to the low- (P<0.001) and the high- (P<0.001) disability
groups. In regard to the occurrences of most of the reported individual comorbid pain conditions,
there were no significant group differences. The percentages of patients reporting chest pain and
abdominal pain increased from the no-disability group through the low- to the high-disability group
with statistically significant differences between the no- and the low-disability groups and the no-
and the high-disability groups (Table 1).
Table 2 presents the combined median values of pain intensity and pain interference of comorbid pain
conditions, as well as days in pain and on sick leave, and visits to doctors because of comorbid pains.
Pain intensity and pain interference, and the number of days in pain increased from the no-disability
group through the low-disability to the high-disability group with statistically significant differences
between all groups. Furthermore, patients in the high-disability group reported significantly more
days on sick leave compared to patients in the no-disability group, and significantly more visits to
doctors compared to patients in the no-and low-disability groups.
General health related medical diagnoses
7Different types of medical diagnoses were reported by 89% of the patients. Allergy was the most
frequent single medical diagnosis reported by the patients (49%), followed by migraine (15%),
asthma (14%), high blood pressure (12%), diabetes (11%), depression (11%) and cardiovascular
diseases (7%). Snoring was reported by 23%, sleep disorders by 21%, and sleep apnea by 2.3 % of
the patients. No significant differences were found in the occurrence of medical diagnoses between
the no- (87%), low- (92%) and the high- (96%) disability groups. However, the number of reported
diagnostic categories was significantly higher in the high-disability group (median 3, IQR 25-75%:
2.5-5.0) than in the no-disability group (median 2, IQR 25-75%: 1.0-3.0) (P< .05). Comparison of the
medical diagnoses in the 12 categories showed significant differences between the disability groups
in three categories: endocrine, cancer and neurosensory diseases (Table 3).
Significant group differences were found in five single diagnoses. Patients in the high-disability group
reported significantly more depression (P<0.01) and nerve lesions (P<0.001) compared to patients in
the no- disability group, and more diabetes compared to patients in the no- (P<0.01) and the low-
(P<0.05) disability groups. Patients in the no-disability group reported significantly less (P<0.05)
fibromyalgia diagnosis compared to patients in the low- and the high-disability groups. Asthma was
significantly (P<0.05) more common in the low-disability group than in the no-disability group.
General health related quality of life
Overall, the quality of life was significantly better among patients reporting no pain-related disability
compared to those with low or high pain-related disability in all RAND-36 subscales as presented in
Table 4.
Discussion
Main findings
The results of the present study indicated that patients reporting different levels of pain-related
disability also differ in terms of comorbid pain conditions and general health-related factors. Patients
reporting higher levels of disability reported more comorbid pain conditions, more visits to doctors
due to comorbid pains, and more general health-related medical diagnoses. The patients in the low-
and high-disability groups experienced their comorbid pains as significantly more intense and
interfering compared to patients in the no-disability group. Furthermore, patients with low or high
pain-related disability indicated poorer quality of life as compared to those with no disability. Thus,
8the GCPS-based disability scoring associated significantly with several factors relating to general
health and well-being.
Comorbid pain conditions
Comparing the frequencies of comorbid pain conditions presented in the literature with the present
findings is challenging due to e.g. differences in study samples, study settings and case definitions.
Two recent reviews reported that the four most common comorbid pain conditions in TMD were
migraine (12%-61%), headache (35%-89%), neck pain (54%-68%) and back pain (16%-64%) [6,26].
Compared to these figures, the occurrences of comorbidities in the present study are near the upper
limits of these reference values, whereas they are approximately of the same magnitude as the
prevalence of comorbid pain complaints in a recent large population-based study [27]. Fibromyalgia
was reported by only 5.8% of the present patients, which is a much lower figure than that presented
earlier [6]. In a recent study participants with mild TMD symptoms reported on average 4.3 comorbid
pains, and those with severe TMD pain complaints, 4.6 comorbid pains, the total number of pains
ranging from 0 to 8 [27]. These figures may be comparable with the numbers of the low-disability
patients (4.2 pains) and the high-disability patients (4.6) of the present study.
Only a few studies have examined the associations of comorbid pains with TMD pain-related
disability as was done in the present study. Supporting our findings, Yap et al. [15] found significant
and positive correlation between the number of other pain conditions and graded chronic pain
severity. In a recent case-control study TMD patients with two or more comorbid pain conditions
reported significantly elevated pain scores on GCPS, as assessed for both TMD pain and other pains,
compared to patients with no, or only one, comorbid pain condition [28]. In the present study the
more disabled TMD patients also experienced their comorbid pains as more bothersome compared to
patients reporting less disability. An association between TMD pain-related disability and pain
comorbidities has also been found in prospective studies demonstrating increased risk for
dysfunctional pain (as measured using the GCPS scale) with widespread pain [8,29].
Medical conditions
The number of reported medical conditions was high (89%), as in previous studies [30].  Allergy was
the most frequently reported single medical diagnosis. Respiratory conditions including allergy have
been shown to occur in TMD patients more frequently compared to controls [9], and to predict first-
9onset TMD [7]. The second most frequently reported single medical diagnoses were those related to
sleep. Approximately one- to two-thirds of TMD patients are reported to suffer from sleep
disturbances [31]. Clinical insomnia has been suggested to play a pathophysiological role in TMD
etiology [32].Only 2.3 % of the present primary care patients reported having a sleep apnea diagnosis,
which is a considerably lower figure compared to the findings of a polysomnographic evaluation
where 28% of TMD pain patients were diagnosed with sleep apnea in a pain clinic [32].
To the best of our knowledge, there exist no previous studies concerning the association between
general health-related factors and TMD pain-related disability except for the finding that the more
disabled patients rate their general health as poorer compared to more functional TMD patients
[14,17].  The present study gave comparable results; patients in the high-disability group estimated
their general health as significantly poorer compared to patients in the low-disability group, and to
those in the no-disability group. The number of reported diagnostic categories was significantly
higher in the high-disability group than in the no-disability group. In an earlier study, a larger number
of medical conditions was found to differentiate TMD patients from controls [30].
High-disability patients reported more depression diagnoses compared to patients reporting no pain-
related disability, which is in accordance with the findings in other studies [14-16]. Fibromyalgia, a
condition considered to reflect generalized pain hyperexcitability, was more frequently reported by
patients in the high- and low-disability groups compared to patients in the no-disability group.
General health-related quality of life
Physical and emotional functioning was shown to decrease significantly with the presence of TMD
and with increased frequency of temple headache in an earlier study [33].  Liegey Dougall et al. [34]
reported that TMD subjects who were estimated to have a high-risk of progressing to chronic TMD
pain reported lower quality of life. There are no earlier studies on the general health-related quality
of life in relation to TMD pain-related disability. In this study, patients in the no-disability group were
significantly better functioning than patients in the other two groups regarding all RAND-36
subscales.
 Methodological considerations
The original RDC/TMD assessment method has been revised and a new, evidence-based DC/TMD
assessment protocol was published in 2014 [35]. As the material for the present study was collected
before the publishing of the DC/TMD assessment protocol [35], the present study utilized the
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original RDC/TMD assessment method. There is good evidence, however, for the reliability and
validity of the RDC/TMD Axis II instruments [35]. Analogously, many different measures for
health-related quality of life exist. We chose RAND-36 as the scoring method in our study because
it is reported to be the most used method for determining quality of life [36].
The cross-sectional study design does not allow drawing conclusions as to the causality of the
reported associations. The subjects of the present study were primary care TMD patients, possibly
limiting the generalizability of the study findings to other patient samples, such as patients treated
in secondary or tertiary care clinics, who usually suffer from more severe symptoms.
As for outcomes of medical diagnoses, we do not know how reliable the patients’ reports of confirmed
diagnoses can be considered compared to those collected from the patient register system. Patients
were interviewed about medical diagnoses, which might increase the reliability.  Presumably, due to
this arrangement the amount of missing data remained very low.
Clinical implications
Patients reporting different levels of pain-related disability in the present study differed from each
other so that patients in the high-disability group reported higher values and patients in the no-
disability lower values on most of the assessed variables. The low-disability patients reported mostly
values in-between these, and thus formed an intermediate group between the no- and high-disability
groups. These findings extended our earlier findings on the psychosocial aspects of TMD pain in
primary care [18], and provided further support for the subdivision of the GCPS grades to include the
intermediate GCPS low-disability subgroup.
Comprehensive diagnostics of TMD patients is recommended as it enables individualized treatment
planning where the aim is to match treatments with the complexity of the condition [6,34]. It is
generally considered that TMD patients with comorbid conditions need comprehensive care
performed by an interdisciplinary team [6]. However, based on the present study findings it seems
that although the non-disabled TMD patients report many comorbid pains, they experience them
largely as non-burdening. This may indicate that reporting other comorbid pains does not necessarily
signal a complicated condition, and that when planning the treatments attention should also be paid
to the impact of comorbid pains.
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Conclusions
The GCPS-based disability scoring associated significantly with several factors relating to the general
health and well-being. These results are complementary to our previous findings on the same primary
care TMD patient sample indicating that GCPS-related disability scoring identifies patients with
different, clinically relevant psychosocial subtypes [18]. The findings of the present study suggest
that GCPS-related disability scoring can be used as a simple screening instrument to identify TMD
patients with different degrees of burdens relating to general well-being to guide individualized
treatment planning.
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Table 1. Comorbid Pain Conditions: Occurrences and Group Differences
Among TMD Patient Subtypes with No, Low, or High Disability
 Frequency %
   No-   Low- High-
Comorbid pain    All disability disability disability
Headache    90.2 88.8   92.6 93.9
Neck pain    85.7 83.1   91.6 87.8
Back pain    74.7 71.9   81.3 77.1
Joint pain    60.4 59.3   59.3 69.4
Chest pain    22.8 14.1      32.4#  44.9*
Abdominal pain    51.4 44.2       57.9#  73.5*
Fibromyalgia pain      5.8   3.8   7.8 10.6
*P<0.001 no vs. high disability group; # P<0.05 no vs. low disability group
Χ2-test
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Table 2. Comorbid Pain Conditions: Medians of Pain Data, Group differences Among TMD
Patient Subtypes with No, Low,  or High Disability
Median (IQR)
No- Low- High-
Pain data All disability disability disability
Pain intensity (0-10) 3.0 2.6 3.6* 4.6*#
(2.0-4.1) (1.7-3.4) (2.6-4.3) (2.9-5.6)
Pain interference (0-10) 2.0 1.6 2.6* 3.7*#
(1.8-3.0) (1.0-2.4) (1.8-3.6) (2.1-5.0)
Days in pain (0-180) 3.0 1.0 4.0* 17.0*#
(0.0-14.0) (0.0-9.5) (0.0-16.5) (7.7-91.2)
Days on sick leave (0-180) 0.0 0.0 0.0 2.0*
(0.0-3.0) (0.0-2.0) (0.0-4.0) (0.0-15.0)
Visits to doctor 1.0 1.0 1.0 4.0*#
(0.0-4.0) (0.0-3.0) (0.0-4.5) (2.0-9.3)
*P<0.05 vs.  no disability group; # P<0.05 vs. low disability group
IQR= interquartile range for 25-75%, Dunns’ method
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Table 3. Medical Diagnoses: Occurrences and Group Differences Among
                TMD Patient Subtypes with No, Low, or High Disability
Frequency (%)
Medical diagnosis No- Low- High-
category           All disability disability disability
Endocrine       7.2   4.5   7.4         20.4***#
Cardiovascular          18.0 16.1 21.3 20.4
Hematologic           1.5 2.1 0.9 0.0
Neurosensory         12.3 9.1 13.9    24.5**
Respiratory                                  51.4        52.9 49.1 49.0
Musculosceletal         26.0 24.0 29.6 28.6
Headache         16.8 13.6 20.4 24.5
Gastrointestinal         12.8 11.2 13.0 20.4
Sleep disorders         38.6 37.2 38.9 44.9
Psychiatric disorders         15.5 14.1 13.9 26.5
Cancer           3.5 3.7#    0.0    10.2##
Other           9.5 11.2 7.4 6.1
* P<0.05, ** P<0.01, *** P<0.001 vs.no disability group
# P<0.05, ## P<0.01 vs. low disability group, Χ2-test
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Table 4. Quality of Life. Medians of RAND-36 subscales and Group Differences
                Among TMD Patient Subtypes with No, Low or High Disability
Median (IQR)
No- Low- High-
RAND-36 subscale disability disability disability
Physical functioning 95.0 90.0* 85.0*
(85.0-100.0) (75.0-100.0) (58.8-96.3)
Physical role functioning 100.0 50.0* 25.0*
(50.0-100.0) (12.5-100.0) (0.0-75.0)
Psychological role
functioning 100.0 100.0* 66.7*
(66.7-100.0) (37.5-100.0) (33.3-100.0)
Energy 70.0 55.0* 50.0*
(55.0-80.0) (45.0-70.0) (35.0-65.0)
Psychological well-being 80.0 72.0* 64.0*
(72.0-88.0) (60.0-84.0) (44.0-81.0)
Social functioning 100.0 75.0* 62.5*
(75.0-100.0) (62.5-87.5) (37.5-87.5)
Bodily pain 67.5 55.0* 37.5*#
(57.5-80.0) (45.0-67.5) (21.9-45.0)
Self-rated general health 70.0 60.0* 45.0*#
(55.0-80.0) (45.0-70.0) (30.0-60.0)
*P<0.05 vs.no disability group; # P<0.05 vs. low disability group
IQR = interquartile range for 25-75%, Χ2-test
